Evidence map›Paper›PMID 25387392›Full record

ArticleRetrovirology2014

Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cells.

Kieran Cashin, Geza Paukovics, Martin R Jakobsen, Lars Østergaard, Melissa J Churchill, Paul R Gorry, Jacqueline K Flynn

Abstract read
In one paragraph

Article in Retrovirology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. IL-15 regulates susceptibility of CD4Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. T cell therapies-are T memory stem cells the answer?Annals of translational medicine · 2015
    Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kieran CashinCenter for Biomedical Research, Burnet Institute, Melbourne, 3004, Australia. kieran@burnet.edu.au.
Geza PaukovicsBurnet Institute Flow Cytometry Core Facility, Melbourne, 3004, Australia. paukovic@burnet.edu.au.
Martin R JakobsenDepartment of Biomedicine, Aarhus University, Aarhus, 237551, Denmark. mrj@immunology.au.dk.
Lars ØstergaardDepartment of Infectious Diseases, Aarhus University, Aarhus, 237551, Denmark. larsoest@rm.dk.
Melissa J ChurchillCenter for Biomedical Research, Burnet Institute, Melbourne, 3004, Australia. churchil@burnet.edu.au.
Paul R GorryCenter for Biomedical Research, Burnet Institute, Melbourne, 3004, Australia. gorry@burnet.edu.au.
Jacqueline K FlynnCenter for Biomedical Research, Burnet Institute, Melbourne, 3004, Australia. jflynn@burnet.edu.au.

Funding

Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
NIAID NIH HHS U19 AI096109NIMH NIH HHS R21 MH100594
6 · The paper itself

Abstract

backgroundCD4(+) memory T-cells are a major target for infection by HIV-1, whereby latent provirus can establish and endure suppressive antiretroviral therapies. Although HIV-1 subtype C strains (C-HIV) account for the majority of HIV-1 infections worldwide, the susceptibility of CD4(+) memory T-cells to infection by CCR5- (R5) and CXCR4-using (X4) C-HIV is unknown. Here, we quantified the susceptibility of naïve and memory CD4(+) T-cell subsets, including stem cell memory T-cells (TSCM), to infection by HIV-1 subtype C (C-HIV) strains from treatment-naïve subjects who progressed from chronic to advanced stages of disease whilst either maintaining CCR5-using (R5) viruses (subjects 1503 and 1854), or who experienced emergence of dominant CXCR4-using (X4) strains (subject 1109).

findingsWe show that R5 and X4 C-HIV viruses preferentially target memory and naïve CD4(+) T-cell subsets, respectively. While TSCM were susceptible to infection by both R5 and X4 C-HIV viruses, the proportion of infected CD4(+) T-cells that were TSCM was higher for R5 strains. Mutagenesis studies of subject 1109 viruses established the V3 region of env as the determinant underlying the preferential targeting of naïve CD4(+) T-cells by emergent X4 C-HIV variants in this subject. In contrast, the tropism of R5 C-HIV viruses for CD4(+) T-cell subsets was maintained from chronic to advanced stages of disease in subjects 1503 and 1854.

conclusionsThis study provides new insights into the natural history of tropism alterations for CD4(+) T-cell subsets by C-HIV strains during progression from chronic to advanced stages of infection. Although not preferentially targeted, our data suggest that TSCM and other memory CD4(+) T-cells are likely to be viral reservoirs in subjects with X4 C-HIV infection.

Indexed as

Viral TropismVirus AttachmentCD4-Positive T-LymphocytesGenotypeHIV-1HumansT-Lymphocyte Subsets

Identifiers

PMID25387392
PMCPMC4236466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.